You're one step closer to unlocking our suite of comprehensive and robust tools.
Fill out the form so we can connect you to the right person.
If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.
NanoVibronix receives approval for wound healing kit in Canada
Brazil Pay TV Down Record Amount In 2019, With Losses Continuing In Q1'20
Case Study: Transforming Sales Enablement Data at a Global Advertising and Media Firm
Impact of COVID 19 on US Video Entertainment Trends
Key Credit Risk Factors When Assessing Banks In The Context Of COVID-19
NanoVibronix Inc. secured regulatory approval to commercialize its WoundShield device in Canada.
The device facilitates soft tissue regeneration and wound healing by using ultrasound. It is already approved in Europe and NanoVibronix plans to pursue regulatory approval in the U.S.